Brief: Acorda Therapeutics - On Dec 31, 2022, Entered New Msa With Catalent Massachusetts Llc, Terminated Prior Manufacturing Services Agreement, Dated Feb 10, 2021
05/01/2023 22:21
Jan 5 (Reuters) - Acorda Therapeutics Inc ACOR.O :
* ACORDA THERAPEUTICS - ON DEC 31, 2022, ENTERED NEW MSA
WITH
CATALENT MASSACHUSETTS LLC, TERMINATED PRIOR MANUFACTURING
SERVICES AGREEMENT, DATED FEB 10, 2021
Further company coverage: ACOR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Acorda Therapeutics
See all newsBrief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale
Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
Live Markets: Biotech companies in 'Darwinian' world as cash remains king
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease